Late Stage Biotech
Letzter Login: 14.02.2019
Performance
-
-22,1 %seit 09.08.2016
-
-29,9 %1 Jahr
-
-5,2 %Ø-Performance pro Jahr
Risiko
-
-54,9 %Max Verlust (bisher)
-
1,82×Risiko-Faktor
Handelsidee
The main focus of this portfolio is the Biotechnology area.
The stocks are screened with for me the most important criteria!
Some points are:
PIPELINE : no "one trick ponys" - its important to have a big and diversified product pipeline!
BALANCE SHEET : enough CASH, low BURN RATE, no DEBT
SHARE STRUCTURE : no massive dilution, low floats are preferred
NEAR TERM CATALYST : its important to have catalyst in the near future (max. 6 months)
MANAGEMENT : is the MGMT following their timelines and is shareholder friendly mehr anzeigen
The stocks are screened with for me the most important criteria!
Some points are:
PIPELINE : no "one trick ponys" - its important to have a big and diversified product pipeline!
BALANCE SHEET : enough CASH, low BURN RATE, no DEBT
SHARE STRUCTURE : no massive dilution, low floats are preferred
NEAR TERM CATALYST : its important to have catalyst in the near future (max. 6 months)
MANAGEMENT : is the MGMT following their timelines and is shareholder friendly mehr anzeigen
Dieser Inhalt ist in der aktuellen Sprache nicht verfügbar.
Stammdaten
Symbol
|
WF0002910T |
Erstellungsdatum
|
09.08.2016 |
Indexstand | |
High Watermark
|
109,3 |
Regeln
Anlageuniversum
Trader
Mitglied seit 16.10.2015